RESUMO
Neutrophil migration from blood into tissues is required for effective innate immune responses against infection. Adhesion of the neutrophil in blood to the vascular endothelium and eventual migration through the vessel wall and accumulation at the site of infection involves different classes of adhesion molecules. In vivo intravital microscopy studies show that different adhesion molecules mediate binding events under shear forces associated with blood flow vs binding events that take place under static conditions. To fully analyze the function of these adhesion molecules in vitro, assays must reflect the hemodynamic forces associated with blood flow. We outline two approaches used to study neutrophil adhesion under conditions that mimic blood flow.
Assuntos
Técnicas de Laboratório Clínico , Hemodinâmica , Neutrófilos/fisiologia , Animais , Biomimética , Velocidade do Fluxo Sanguíneo , Células CHO , Adesão Celular , Técnicas de Laboratório Clínico/instrumentação , Cricetinae , Cricetulus , Humanos , Modelos Biológicos , Resistência ao Cisalhamento , Células U937RESUMO
The severity of allergic asthma is dependent, in part, on the intensity of peribronchial inflammation. P-selectin is known to play a role in the development of allergen-induced peribronchial inflammation and airway hyperreactivity. Selective inhibitors of P-selectin-mediated leukocyte endothelial-cell interactions may therefore attenuate the inflammatory processes associated with allergic airway disease. Novel P-selectin inhibitors were created using a polyvalent polymer nanoparticle capable of displaying multiple synthetic, low molecular weight ligands. By assembling a particle that presents an array of groups, which as monomers interact with only low affinity, we created a construct that binds extremely efficiently to P-selectin. The ligands acted as mimetics of the key binding elements responsible for the high-avidity adhesion of P-selectin to the physiologic ligand, PSGL-1. The inhibitors were initially evaluated using an in vitro shear assay system in which interactions between circulating cells and P-selectin-coated capillary tubes were measured. The nanoparticles were shown to preferentially bind to selectins expressed on activated endothelial cells. We subsequently demonstrated that nanoparticles displaying P-selectin blocking arrays were functionally active in vivo, significantly reducing allergen-induced airway hyperreactivity and peribronchial eosinophilic inflammation in a murine model of asthma.
Assuntos
Anti-Inflamatórios/uso terapêutico , Asma/tratamento farmacológico , Selectina-P/metabolismo , Alérgenos/imunologia , Animais , Anti-Inflamatórios/química , Anti-Inflamatórios/metabolismo , Asma/imunologia , Asma/metabolismo , Biopolímeros/metabolismo , Hiper-Reatividade Brônquica/tratamento farmacológico , Hiper-Reatividade Brônquica/imunologia , Hiper-Reatividade Brônquica/metabolismo , Bronquite/tratamento farmacológico , Bronquite/imunologia , Bronquite/metabolismo , Adesão Celular , Migração e Rolagem de Leucócitos/efeitos dos fármacos , Leucócitos/efeitos dos fármacos , Leucócitos/imunologia , Ligantes , Lipídeos/química , Pulmão/citologia , Glicoproteínas de Membrana/metabolismo , Camundongos , Camundongos Knockout , Microesferas , Modelos Imunológicos , Selectina-P/genética , Mucosa Respiratória/metabolismoRESUMO
Gammadelta T cells are innate immune cells that participate in host responses against many pathogens and cancers. Recently, phosphoantigen-based drugs, capable of expanding gammadelta T cells in vivo, entered clinical trials with the goal of enhancing innate immune system functions. Potential shortcomings of these drugs include the induction of nonresponsiveness upon repeated use and the expansion of only the Vdelta2 subset of human gammadelta T cells. Vdelta1 T cells, the major tissue subset, are unaffected by phosphoantigen agonists. Using FACS-based assays, we screened primary bovine cells for novel gammadelta T cell agonists with activities not encompassed by the current treatments in an effort to realize the full therapeutic potential of gammadelta T cells. We identified gammadelta T cell agonists derived from the condensed tannin fractions of Uncaria tomentosa (Cat's Claw) and Malus domestica (apple). Based on superior potency, the apple extract was selected for detailed analyses on human cells. The apple extract was a potent agonist for both human Vdelta1 and Vdelta2 T cells and NK cells. Additionally, the extract greatly enhanced phosphoantigen-induced gammadelta T cell expansion. Our analyses suggest that a tannin-based drug may complement the phosphoantigen-based drugs, thereby enhancing the therapeutic potential of gammadelta T cells.
Assuntos
Unha-de-Gato , Divisão Celular/efeitos dos fármacos , Frutas , Subunidade alfa de Receptor de Interleucina-2/imunologia , Malus , Extratos Vegetais/farmacologia , Receptores de Antígenos de Linfócitos T gama-delta/agonistas , Taninos/farmacocinética , Regulação para Cima/efeitos dos fármacos , Animais , Unha-de-Gato/química , Bovinos , Frutas/química , Humanos , Subunidade alfa de Receptor de Interleucina-2/biossíntese , Células Matadoras Naturais/imunologia , Células Matadoras Naturais/metabolismo , Malus/química , Neoplasias/tratamento farmacológico , Neoplasias/imunologia , Extratos Vegetais/química , Extratos Vegetais/uso terapêutico , Receptores de Antígenos de Linfócitos T gama-delta/imunologia , Receptores de Antígenos de Linfócitos T gama-delta/metabolismo , Linfócitos T , Taninos/química , Taninos/uso terapêuticoRESUMO
Alveolar macrophages (AMs) avidly bind and ingest inhaled environmental particles and bacteria. To identify the particle binding receptor(s) on human AMs, we used functional screening of anti-human AM hybridomas and isolated a mAb, PLK-1, which inhibits AM binding of unopsonized particles (e.g., TiO2, latex beads; 63 +/- 5 and 67 +/- 4% inhibition, respectively, measured by flow cytometry; n = 11) and unopsonized bacteria ( approximately 84 and 41% inhibition of Escherichia coli and Staphylococcus aureus binding by mAb PLK-1, respectively). The PLK-1 Ag was identified as the human class A scavenger receptor (SR) MARCO (macrophage receptor with collagenous structure) by observing specific immunolabeling of COS cells transfected with human MARCO (but not SR-AI/II) cDNA and by immunoprecipitation by PLK-1 of a protein of appropriate molecular mass (approximately 70 kDa) from both normal human bronchoalveolar lavage cells (>90% AMs) and human MARCO-transfected COS cells. PLK-1 also specifically inhibited particle binding by COS cells, only after transfection with human MARCO cDNA. Immunostaining showed specific labeling of AMs within human lung tissue, bronchoalveolar lavage samples, as well as macrophages in other sites (e.g., lymph node and liver). Using COS transfectants with different truncated forms of MARCO, allowed epitope mapping for the PLK-1 Ab to MARCO domain V between amino acid residues 420 and 431. A panel of Abs to various SRs identified expression on AMs, but failed to inhibit TiO2 or S. aureus binding. The data support a dominant role for MARCO in the human AM defense against inhaled particles and pathogens.
Assuntos
Macrófagos Alveolares/imunologia , Receptores Imunológicos/fisiologia , Adulto , Anticorpos Monoclonais/imunologia , Proteínas de Ciclo Celular/fisiologia , Humanos , Fagocitose , Proteínas Quinases/fisiologia , Proteínas Serina-Treonina Quinases , Estrutura Terciária de Proteína , Proteínas Proto-Oncogênicas/fisiologia , Receptores Imunológicos/análise , Receptores Imunológicos/química , Titânio/metabolismo , Quinase 1 Polo-LikeRESUMO
Alveolar macrophages (AMs) and epithelial cells (ECs) are the first cells in the lung to encounter inhaled environmental particles. The initial interaction between AMs and particles is mediated by specific scavenger receptors, but the nature of the structure(s) on ECs that also bind particles has not been well-described. To characterize the nature of the EC particle receptor, we screened a panel of mouse anti-human EC hybridomas for functional blockade of EC particle binding. This strategy identified a monoclonal antibody (MAb) (EPR1) that blocks binding of titanium dioxide (TiO(2)) particles to the EC line which served as the immunogen (A549), as well as to other EC lines (Beas 2-B, HTB54, HeLa, and MDA-MB-435S). EPR1 demonstrated specific labeling of ECs using immunohistology techniques and its expression could be quantitated by flow cytometry of permeabilized ECs in suspension. MAbs such as EPR1 may prove useful in further analysis of receptors for inhaled particles on lung epithelial cells.
Assuntos
Anticorpos Monoclonais/imunologia , Pulmão/imunologia , Animais , Epitélio/imunologia , Epitélio/metabolismo , Humanos , Proteínas Inibidoras de Apoptose , Pulmão/metabolismo , Receptores de Superfície Celular/imunologia , Survivina , Titânio/metabolismoRESUMO
Maternal asthma is a risk factor for development of asthma in children, but mechanisms remain unclear. Offspring of asthmatic mother mice (sensitized and repeatedly exposed to OVA Ag) showed airway hyperresponsiveness and allergic pulmonary inflammation after an intentionally suboptimal OVA sensitization and exposure protocol that had little effect on normal offspring. Similar results were obtained when offspring of OVA-allergic mothers were exposed to an unrelated allergen, casein, indicating that the maternal effect is allergen independent and not transferred by OVA-specific Abs. Premating treatment with neutralizing anti-IL-4 Ab or reduction of maternal allergen exposure abrogated the maternal effect, showing a critical mechanistic role for IL-4 and suggesting an additional benefit of allergen avoidance.